Precision Medicine &
What is Precision Medicine?
Precision Medicine is an approach which enables doctors and researchers to develop treatments that are effective for particular groups of patients, using advanced genomic, imaging and information technologies. Precision medicine ensures that the right patient gets the right treatment at the right time and will provide safer and more cost-effective treatments.
Healthtech refers to technologies used for medical or healthcare that have been enabled by modern advances in computing and manufacturing.
Scotland is home to one of the largest life sciences clusters in Europe, producing ground-breaking research and innovation in human healthcare and technology. The life sciences represent a priority sector of economic significance by the Scottish Government and Scotland is fast becoming one of the most effective places to develop innovations and commercial enterprises.
Precision Medicine Market
In 2020, total turnover in the Scottish Life Sciences growth sector was £3,219.3 million
Total turnover for businesses in the wider Life Sciences cluster was estimated at £7,411.7 million in 2019
Total exports from the sector stood at £1.8 bn in 2019, accounting for 2.1% of Scotland’s total exports
The £1B Queen Elizabeth University Hospital is the largest critical care complex in Western Europe.
30% of all the biosafety testing across Europe happens in Glasgow
More than 380 Life Sciences companies in the Glasgow city region turn over £325 million annually
Glasgow’s thriving life sciences sector, underpinned by a robust partnership of academia, industry and the NHS, provides ideal conditions for health innovation to flourish. With four universities, the largest acute hospital complex in Western Europe and a world-leading talent pool, the region produces and attracts international leaders in precision medicine, medical technology, and translational medicine.
Led by the University of Glasgow, the city is now a world leading and business-friendly centre for precision medicine and imaging, providing unique access to electronic patient records, data, and world-class clinical trial infrastructure.
Regional assets of note include world-class R&D centres engaged in novel imaging technology, including:
The University of Glasgow-led Imaging Centre of Excellence (ICE), Clinical Innovation Zone, and the Precision Medicine Scotland Innovation Centre (PMS-IC) at the Queen Elizabeth University Hospital site. The UK’s first high resolution 7 Tesla Magnetic Resonance Imaging (MRI) scanner in a clinical setting is hosted in the Imaging Centre of Excellence at the QEUH, which includes 22,000 ft of co-working space.
A new Living Laboratory for Precision Medicine will sit adjacent to the QEUH and focus on the adoption of healthcare innovations into clinical practice, and is projected to deliver 446 high-value jobs and £136 million GVA over an 8-year period.
The new industry-led Medicines Manufacturing Innovation Centre near Glasgow Airport will accelerate adoption of novel manufacturing technologies for small molecule pharmaceuticals and fine high value chemicals.
The Digital Health & Care Innovation Centre, a collaboration between the University of Strathclyde and Glasgow School of Art supports transformational collaboration between universities and businesses. The innovation centre helps innovators develop prototypes and take them to market, as well as offering a demonstration and simulation environment alongside living lab test beds.
Latest News Stories
- Strathclyde Computer Science graduate wins Best Engineering Project prize
- Research ties between Scotland and Australia could advance shipbuilding on the Clyde
- NMIS appoints former UKRI Challenge Director as Chief Executive Officer
- Pioneering cross border collaboration provides crucial support to UK forging and forming community
- Wind Turbine Blade Recycling Project Powers up at the Lightweight Manufacturing Centre
- University of Strathclyde and Renewable Parts to advance the UK-based remanufacture supply chain